BET inhibition as a new strategy for the treatment of gastric cancer
Gastric cancer is one of the most common malignancies and a leading cause of cancer death worldwide. The prognosis of stomach cancer is generally poor as this cancer is not very sensitive to commonly used chemotherapies. Epigenetic modifications play a key role in gastric cancer and contribute to the development and progression of this malignancy. In order to explore new treatment options in this target area we have screened a library of epigenetic inhibitors against gastric cancer cell lines...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Copyright holder:
- Montenegro et al.
- Copyright date:
- All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record